Skip to main content

Advertisement

SpringerLink
Log in

Treatment of renal osteodystrophy with 1α-hydroxycholecalciferol (1α-OH-D3) in conjunction with a high dialysate calcium

  • Section I — Verbal Presentations
  • Chapter II Therapeutics of Vitamin D Metabolites
  • Published:
Calcified Tissue Research Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Bouillon, R., Verberckmoes, R., De Moor, P.: Influence of dialysate calcium concentration and vitamin D on serum parathyroid hormone during repetitive dialysis. Kidney int.7, 422–32 (1975)

    PubMed  Google Scholar 

  • Chalmers, T. M., Hunter, J. O., Davie, M. W., Szoz, K. F., Pelc, B., Kodicek, E.: 1α-hydroxycholecalciferol as a substitute for the kidney hormone 1,25-dihydroxycholecalciferol in chronic renal failure. Lancetii, 696–9 (1973)

    Google Scholar 

  • DeLuca, H. F.: The kidney as an endocrine organ involved in the function of vitamin D. Amer. J. Med.58, 39–47 (1975)

    PubMed  Google Scholar 

  • Denney, J. O., Sherrard, D. J., Nelp, W. B., Chestnut III, C. H., Baylink, D. J.: Total body calcium and long term calcium balance in chronic renal failure. J. Lab. clin. Med.82, 226–40 (1973)

    PubMed  Google Scholar 

  • Ellis, H. A., Peart, K.: Azotaemic renal osteodystrophy: a quantitative study on iliac bone. J. clin. Path.26, 83–101 (1973)

    PubMed  Google Scholar 

  • Fournier, A. E., Bordier, P. J., Gueris, J., Chanard, J., Marie, P., Ferriere, C., Osario, M., Bedrossian, J., DeLuca, H. F.: 1α-hydroxycholecalciferol and 25-hydroxycholecalciferol in renal bone disease. In: Proc. Europ. Dial. Transplant Ass., Vol. 12, p. 227–36 (J. F. Moorhead, ed.), Tunbridge Wells: Pitman Medical, 1975

    Google Scholar 

  • Goldsmith, R. S., Furszyfer, J., Johnson, W. J., Fournier, A. E., Arnaud, C. D.: Control of secondary hyperparathyroidism during long-term haemodialysis. Amer. J. Med.50, 692–9 (1971)

    PubMed  Google Scholar 

  • Pierides, A. M., Simpson, W., Ward, M. K., Ellis, H. A., Dewar, J. H., Kerr, D. N. S.: Variable response to long-term 1α-hydroxycholecalciferol in haemodialysis osteodystrophy. Lanceti, 1092–5 (1976)

    Google Scholar 

  • Tougaard, L., Sorensen, E., Brochner-Mortensen, J., Christensen, M. S., Rodbro, P., Sorensen, A. W. S.: Controlled trial of 1α-hydroxycholecalciferol in chronic renal failure. Lanceti, 1044–7 (1976)

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medical Renal Unit, University Depts. of Medicine and Pathology, Edinburgh Royal Infirmary, Edinburgh, U.K.

    R. J. Winney, J. M. Bone, T. J. Anderson & J. S. Robson

Authors
  1. R. J. Winney
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. M. Bone
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. T. J. Anderson
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J. S. Robson
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Winney, R.J., Bone, J.M., Anderson, T.J. et al. Treatment of renal osteodystrophy with 1α-hydroxycholecalciferol (1α-OH-D3) in conjunction with a high dialysate calcium. Calc. Tis Res. 22 (Suppl 1), 94–100 (1976). https://doi.org/10.1007/BF02064047

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02064047

Keywords

Search

Navigation